ValorQ4, 24Q1, 25Q2, 25Q3, 25TTMSelling/general/admin expenses115.14 M110.72 M101.61 M109.15 M436.62 MResearch & development18.3 M16.26 M14.87 M14.19 M63.63 MOperating income71.33 M53.87 M58.49 M67.4 M251.09 MNon-Operating Income, Total-712 K-8.7 M-7.21 M-7.42 M-24.04 MInterest expense, net of interest capitalized—————Non-Operating Income, excl. Interest Expenses-114 K000-114 KUnusual income/expense-598 K-8.7 M-7.21 M-7.42 M-23.93 MPretax income70.74 M45.17 M51.28 M59.98 M227.17 MEquity in earnings—————Taxes12.76 M11.14 M12.6 M15.23 M51.73 MNon-controlling/minority interest—————After tax other income/expense—————Net income before discontinued operations128.72 M79.2 M89.97 M104.72 M402.6 MDiscontinued operations-70.74 M-45.17 M-51.28 M-59.98 M-227.17 MNet income57.98 M34.03 M38.68 M44.74 M175.44 MDilution adjustment—————Preferred dividends—————Diluted net income available to common stockholders57.98 M34.03 M38.68 M44.74 M175.44 MBasic earnings per share (Basic EPS)1.170.710.810.963.65Diluted earnings per share (Diluted EPS)1.170.70.810.953.63Average basic shares outstanding50.33 M48.11 M47.59 M46.79 M192.82 MDiluted shares outstanding50.73 M48.35 M47.66 M46.99 M193.73 MEBITDA142.13 M82.57 M86.79 M94.7 M406.19 MEBIT71.33 M53.87 M58.49 M67.4 M251.09 MCost of revenue137.55 M129.15 M132.57 M136.58 M535.85 MOther cost of goods sold—————Depreciation & amortization (cash flow)70.8 M28.7 M28.3 M27.3 M155.1 M
Haemonetics Corporation
Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen Latham in the 1970s.
Today, the company has expanded and has offices located in 16 countries. The company employs more than 1,800 people and markets its products in over 50 countries. Revenue is derived nearly equally from its three major markets -- Asia, Europe, and the Americas.